Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.

@article{Fernndez2003GangliosidebasedVA,
  title={Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.},
  author={Luis E. Fern{\'a}ndez and Daniel F. Alonso and Daniel Eduardo Gomez and Ana Mar{\'i}a Carballido V{\'a}zquez},
  journal={Expert review of vaccines},
  year={2003},
  volume={2 6},
  pages={
          817-23
        }
}
This review shall present an update in anticancer ganglioside-based immunotherapies, with particular emphasis on molecular vaccines and anti-idiotype mAbs produced by the Center of Molecular Immunology (Havana, Cuba). The project comprises vaccines of N-acetyl or N-glycolylneuraminic acid GM3 ganglioside incorporated into very small proteoliposomes and anti-idiotype antibodies to glycolylated gangliosides. Development of these vaccine preparations from preclinical models of melanoma, breast and… CONTINUE READING

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

Serum total gangliosides level: clinical prognostic implication.

  • Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

  • Clinical & developmental immunology
  • 2010
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 52 REFERENCES